[{"Assets_0_Q1_USD":"682774000.0","CIK":"1628171","CommonStockSharesIssued_0_Q1_shares":"74227672.0","CommonStockSharesOutstanding_0_Q1_shares":"74227672.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.78","Industry":"Specialty Chemicals","Market":"NASDAQ","Market Cap":"1775342076.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-55160000.0","NetIncomeLoss_1_Q1_USD":"-57647000.0","OfficialName":"Revolution Medicines Inc. Common Stock","ProfitLoss_1_Q1_USD":"-57647000.0","RevenuesConverted_1_Q1_USD":"7578000.0","SP500":null,"Sector":"Consumer Durables","StockholdersEquity_0_Q1_USD":"550993000.0","Ticker":"RVMD","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":"74162363.0","filed":"20220509","footnote":null,"form":"10-Q","fp":"Q1","fy":"2022.0","name":"REVOLUTION MEDICINES, INC.","period":"20220331","qtrs":"0","uom":"USD"}]